Welcome to our dedicated page for BlueLinx Holdings SEC filings (Ticker: BXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlueLinx Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlueLinx Holdings's regulatory disclosures and financial reporting.
BlueLinx Holdings Inc. director Marietta Edmunds Zakas reported routine equity compensation activity. On May 18, 2026, she received a grant of 2,749 restricted stock units (RSUs), each representing a contingent right to one share of common stock, vesting on the first anniversary of the grant date.
On May 19, 2026, 2,074 RSUs vested and were converted into the same number of common shares, increasing her direct common stock holdings to 5,965 shares. Vested shares from both awards are scheduled to be delivered to her within 30 days after their respective vesting dates. After these transactions, she holds both common shares and an outstanding RSU award, reflecting standard director compensation rather than open-market trading.
BlueLinx Holdings Inc. director Carol B. Yancey reported compensation-related equity activity. On May 19, 2026, 2,074 restricted stock units vested and converted into the same number of common shares, increasing her direct common stock holdings to 9,517 shares. The filing notes that vested shares will be delivered to her within 30 days of vesting.
On May 18, 2026, she also received a grant of 2,749 restricted stock units, each representing a contingent right to one share of common stock, which vest on the first anniversary of the grant date. These transactions reflect routine director equity compensation and do not involve any open-market buying or selling.
BlueLinx Holdings Inc. director J. David Smith reported compensation-related equity activity rather than open-market trading. On May 19, 2026, he exercised 2,074 restricted stock units into an equal number of common shares, bringing his directly held common stock to 16,517 shares. Footnotes state these vested shares will be delivered to him within 30 days after the vesting date.
On May 18, 2026, he also received a grant of 2,749 restricted stock units, each representing a contingent right to one share of common stock. Separate holding entries show multiple vested RSU awards that will be delivered within 30 days after specified future dates or upon the earlier end of his Board service, highlighting that a substantial portion of his position remains in deferred stock units.
BlueLinx Holdings Inc. director Lewis B. Mitchell reported equity compensation activity and a vesting event. On May 19, 2026, 2,074 restricted stock units vested and were converted into the same number of shares of Common Stock, increasing his directly held shares to 38,451. The filing notes that vested shares will be delivered to him within 30 days of vesting.
Separately, on May 18, 2026, Mitchell received a grant of 2,749 restricted stock units, each representing a contingent right to one common share. These RSUs vest on the first anniversary of the grant date, with shares to be delivered within 30 days after vesting.
BlueLinx Holdings Inc. director Keith Haas reported routine equity compensation activity involving restricted stock units (RSUs). On May 19, 2026, 2,074 RSUs vested and were converted into the same number of common shares, bringing his directly held common stock to 5,965 shares.
Separately, on May 18, 2026, he received a new grant of 2,749 RSUs, each representing a contingent right to one share of common stock. These RSUs vest on the first anniversary of the grant date, with vested shares to be delivered within 30 days after vesting.
BlueLinx Holdings Inc. director Kim S. Fennebresque reported equity compensation activity. On May 19, 2026, he exercised 3,218 restricted stock units into 3,218 shares of common stock at an exercise price of $0.0000 per share, bringing his direct common stock holdings to 12,982 shares.
On May 18, 2026, he also received a grant of 4,266 restricted stock units, each representing a contingent right to one common share. In addition to his direct holdings, a grantor trust holds 34,138 shares of common stock and several blocks of restricted stock units covering 22,253, 15,108, 9,485 and 21,334 underlying common shares, with delivery generally tied to vesting and specified future dates or board service termination.
BlueLinx Holdings Inc. director Anuj Dhanda reported equity compensation activity involving restricted stock units (RSUs). On May 19, 2026, 2,074 RSUs vested and were converted into the same number of shares of common stock, increasing his direct holdings to 4,975 common shares. Separately, on May 18, 2026, he received a grant of 2,749 RSUs, each representing a contingent right to one share of common stock. The RSUs vest on the first anniversary of the grant date, with vested shares to be delivered within 30 days of vesting. These are compensation-related awards and conversions, with no open-market purchases or sales disclosed.
BlueLinx Holdings Inc. director Christina M. Corley reported compensation-related equity activity. On May 18, 2026, she received 2,749 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock that vests on the first anniversary of grant.
On May 19, 2026, 1,297 RSUs vested and were converted into 1,297 shares of common stock, reflecting an exercise or conversion of a derivative security at a price of $0.00 per unit. After these transactions, she directly holds 1,297 shares of common stock, with delivery of vested shares to occur no later than 30 days after the respective vesting dates.
BlueLinx Holdings Inc. reported results from its 2026 Annual Meeting of Stockholders, where nine directors were up for election, three key governance items were on the ballot, and an equity incentive plan amendment was considered.
Stockholders re-elected eight directors, while former CEO Mitchell B. Lewis did not receive a majority of votes cast for his seat. In line with the company’s bylaws, he tendered an irrevocable resignation offer, which the board, following a unanimous recommendation from the Nominating and Governance Committee, unanimously rejected after reviewing his experience, independence status under NYSE standards and overall board composition.
Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending January 2, 2027, approved the advisory vote on executive compensation, and approved an amendment to the 2021 Long-Term Incentive Plan to increase the shares reserved for issuance. Lewis will step down as chairman and member of the Nominating Committee, with Marietta Edmunds Zakas becoming its new chair.
BlueLinx Holdings Inc. ownership disclosure: the Reporting Persons (Tontine Capital entities and Jeffrey L. Gendell) report beneficial ownership of 739,523 shares of Common Stock, representing 9.4% of the issued and outstanding shares. The filing states Tontine Capital Overseas Master Fund II, L.P. and Tontine Asset Associates, LLC each have shared voting and dispositive power over 506,245 shares ( 6.4%), based on 7,867,196 shares outstanding as of March 20, 2026.
The statement clarifies organizational roles: TAA is general partner of TCOM II, TM is general partner of TFP, and Mr. Gendell is the managing member directing those entities. The disclosure is an amendment to a Schedule 13G/A and lists shared voting and dispositive power for the reported holdings.